CD4 and coinfection: Thus, together with the finding, that other adverse factors at study entry such as lower CD4 counts in the HIV/HCV co-infected patients, did also not correspond to differences in survival on cART makes us confident that indeed the quality of HIV control is the primary key factor of survival irrespective from HCV co-infection.